← Open Payments lookup

MONA PATEL: Open Payments

NPI 1154080547 · CHESAPEAKE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,922 in 135 payments from 16 companies in 2025. Trend: 2023 $2,315 · 2024 $3,302 · 2025 $2,922

Food & beverage: $2,922
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.25$485
ABBVIE INC.19$407
Alkermes, Inc.11$382
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)13$287
Otsuka America Pharmaceutical, Inc.15$280
Janssen Pharmaceuticals, Inc10$228
Vanda Pharmaceuticals Inc.8$209
Supernus Pharmaceuticals, Inc.7$131
Neurocrine BioSciences, Inc.5$89
Teva Pharmaceuticals USA, Inc.6$85

Products named: COBENFY, VRAYLAR, REXULTI, CAPLYTA, LYBALVI, FANAPT, ARISTADA, SPRAVATO.

Industry payments across VA — which companies pay providers there.